Immunogenicity of a synthetic peptide vaccine from glucosyltransferase.
- Author:
Changzheng SONG
1
;
Jian ZHAO
;
Jinxiang HAN
;
Hainan HUANG
;
Heping PAN
;
Hao LIANG
Author Information
- Publication Type:Journal Article
- MeSH: Amino Acid Sequence; Animals; Antibodies; blood; Bacterial Adhesion; drug effects; Dose-Response Relationship, Drug; Glucosyltransferases; antagonists & inhibitors; genetics; immunology; Immune Sera; pharmacology; Immunization; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Oligopeptides; administration & dosage; chemical synthesis; immunology; Rats; Streptococcus mutans; drug effects; physiology; Vaccines, Subunit; administration & dosage; chemical synthesis; immunology
- From: Chinese Journal of Stomatology 2002;37(6):459-462
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo measure the immunogenicity of a synthetic peptide of glucosyltransferase (GTF) for designing synthetic peptide-based vaccine of dental caries.
METHODSA fusion 27-mer peptide, containing the conserved regions within catalytic and glucan-binding domains of GTF, was synthesized. Serum antibodies to the synthetic peptide were determined by ELISA method. Inhibitions of both GTF activity and S. mutans adherence were detected for the functions of antisera.
RESULTSThe sequence of fusion peptide vaccine was ANDVDNSNPVVQAEQLYFRANGVQVKG. The spleen weights of immunized mice were heavier than the control ones. Specific antibodies were effectually elicited. The immune sera not only inhibited GTF enzymatic activity but also inhibited the vitro adherence of S. mutans.
CONCLUSIONSThe peptide vaccine which involves antibody-mediated inhibition of the catalytic and the glucan-binding activities of GTF may be valuable for controlling the dental caries.
